Swiss Re Investors' Day 2013: George Quinn video explains the key points
» Report
Einige Inhalte dieser Seite sind nur für Abonnenten sichtbar.
Anmelden oder
Jetzt abonnieren!
Archiv: Unternehmen
Sandoz launches Phase III clinical trial for biosimilar etanercept
» Report
N e w ron places new shares under the up to 10% share capital increase resolved on April 18, 2013
» Report
Swiss Re confirms strategy at Investors' Day, targets for higher returns in Life & Health business
» Report
Stabile Stromtarife 2014
» Report
N e w ron platziert neu ausgegebene Aktien im Rahmen der am 18. April 2013 beschlossenen (bis zu 10%) Kapitalerhöhung
» Report
Large order for Oerlikon carpet yarn machinery
» Report
Grossbestellung für Oerlikon Teppichgarnanlage
» Report
ADB Group reports adoption of all resolutions at its Annual General Meeting of Shareholders
» Report
KOF Konjunkturprognose Sommer: Schweizer Wirtschaft wächst trotz Rezession im Euroraum
» Report
FDA grants Breakthrough Therapy designation to Novartis' serelaxin (RLX030) for acute heart failure
» Report
Nobel Biocare announces new digital workflow and new regenerative product at Global Symposium in New York
» Report
Succession planning for the Swiss Life Germany and Switzerland Executive Boards
» Report
Nachfolgeregelungen in den Geschäftsleitungen von Swiss Life Deutschland und Schweiz
» Report
SGS View presented on GRI G4
» Report
SGS Academy South Africa Launches New Training Opportunities
» Report
mondoBIOTECH holding AG (SIX:RARE) announces the results of its Annual General Meeting and the election of the Board of Directors
» Report
Kuoni ernennt interimistischen CEO
» Report
Eastern Property Holdings Re-elects Auditors at AGM and Announces New Management Agreement with Valartis International Ltd.
» Report
FINMA-Rundschreiben "Limitierung gruppeninterner Positionen – Banken" tritt in Kraft
» Report
